Goldenwell Biotech (GWLL) Shares Outstanding (Diluted Average) (2023 - 2025)

Goldenwell Biotech has reported Shares Outstanding (Diluted Average) for 3 years, with the latest figure at $96.4 million in Q3 2025.

• For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $96.4 million; the trailing twelve-month figure through Sep 2025 stood at $96.4 million (changed 0.0% YoY), and the FY2024 full-year result was $99.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Diluted Average) for Q3 2025 stood at $96.4 million, roughly flat from $96.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $99.0 million in Q4 2023, with the low at $96.4 million in Q2 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $97.7 million across 3 years, with a median of $97.7 million in 2023.
• The largest YoY upside for Shares Outstanding (Diluted Average) was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
• Goldenwell Biotech's Shares Outstanding (Diluted Average) stood at $99.0 million in 2023, then changed by 0.0% to $99.0 million in 2024, then declined by 2.59% to $96.4 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $96.4 million (Q3 2025), $96.4 million (Q2 2025), and $99.0 million (Q1 2025), per Business Quant data.